Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 353, Issue 1, 2015, Pages 44-51

  Sullivan, Laura C ^a   Berg, Kelly A ^a   Clarke, William P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; CARRAGEENAN; DELTA OPIATE RECEPTOR; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN E2;

ADULT; ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXPOSURE; IN VIVO STUDY; MALE; METABOLITE; NERVE CELL CULTURE; NONHUMAN; PAIN RECEPTOR; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; RAT MODEL; REGULATORY MECHANISM; SENSORY NERVE CELL; THERMAL ALLODYNIA; THERMAL STIMULATION; AGONISTS; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; HYPERALGESIA; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TRIGEMINUS GANGLION;

ANIMALS; ARACHIDONIC ACID; BRADYKININ; CELLS, CULTURED; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; HYPERALGESIA; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; MALE; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SENSORY RECEPTOR CELLS; TRIGEMINAL GANGLION;

EID: 84923366043     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.221366     Document Type: Article

References (36)

1. Ahlbeck K (2011) Opioids: a two-faced Janus. Curr Med Res Opin 27:439-448.
2. Bakhle YS, Moncada S, de Nucci G, and Salmon JA (1985) Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. Br J Pharmacol 86:55-62.
3. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, and Vallejo R (2008) Opioid complications and side effects. Pain Physician 11(2, Suppl):S105-S120.
4. Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, and Clarke WP (2007a) Rapid modulation of micro-opioid receptor signaling in primary sensory neurons. J Pharmacol Exp Ther 321:839-847.
5. Berg KA, Rowan MP, Gupta A, Sanchez TA, Silva M, Gomes I, McGuire BA, Portoghese PS, Hargreaves KM, Devi LA, et al. (2012) Allosteric interactions between δ and k opioid receptors in peripheral sensory neurons. Mol Pharmacol 81:264-272.
6. Berg KA, Rowan MP, Sanchez TA, Silva M, Patwardhan AM, Milam SB, Hargreaves KM, and Clarke WP (2011) Regulation of k-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo. J Pharmacol Exp Ther 338:92-99.
7. Berg KA, Zardeneta G, Hargreaves KM, Clarke WP, and Milam SB (2007b) Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 144:889-897.
8. Chen JJ, Dymshitz J, and Vasko MR (1997) Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 51:666-673.
9. Dionne RA, Lepinski AM, Gordon SM, Jaber L, Brahim JS, and Hargreaves KM (2001) Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 70:66-73.
10. Fields HL, Emson PC, Leigh BK, Gilbert RF, and Iversen LL (1980) Multiple opiate receptor sites on primary afferent fibres. Nature 284:351-353.
11. Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, Lipman AG, Bookbinder M, Sanders SH, Turk DC, et al.; American Pain Society Quality of Care Task Force (2005) American Pain Society recommendations for improving the quality of acute and cancer pain management. Arch Intern Med 165:1574-1580.
12. Gupta A, Bodin L, Holmström B, and Berggren L (2001) A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 93:761-770.
13. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
14. Joris J, Costello A, Dubner R, and Hargreaves KM (1990) Opiates suppress carrageenaninduced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43:95-103.
15. Joris JL, Dubner R, and Hargreaves KM (1987) Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth Analg 66:1277-1281.
16. Likar R, Koppert W, Blatnig H, Chiari F, Sittl R, Stein C, and Schäfer M (2001) Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Symptom Manage 21:330-337.
17. Lo TN, Saul WF, and Lau SS (1987) Carrageenan-stimulated release of arachidonic acid and of lactate dehydrogenase from rat pleural cells. Biochem Pharmacol 36:2405-2413.
18. Manzoni OJ and Williams JT (1999) Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J Neurosci 19:6629-6636.
19. Needleman P, Wyche A, Bronson SD, Holmberg S, and Morrison AR (1979) Specific regulation of peptide-induced renal prostaglandin synthesis. J Biol Chem 254:9772-9779.
20. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, and Przewlocki R (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141:283-291.
21. Pasternak GW and Pan YX (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65:1257-1317.
22. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, and Hargreaves KM (2005) Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25:8825-8832.
23. Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, and Hargreaves KM (2006) PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125:114-124.
24. Przewlocki R and Przewłocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429:79-91.
25. Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, and Hargreaves KM (2009) Peripheral delta opioid receptors require priming for functional competence in vivo. Eur J Pharmacol 602:283-287.
26. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, et al. (2002) Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99:10150-10155.
27. Solheim N, Rosseland LA, and Stubhaug A (2006) Intra-articular morphine 5 mg after knee arthroscopy does not produce significant pain relief when administered to patients with moderate to severe pain via an intra-articular catheter. Reg Anesth Pain Med 31:506-513.
28. Stein C and Lang LJ (2009) Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 9:3-8.
29. Stein C, Schäfer M, and Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003-1008.
30. Stein C and Zollner C (2009) Opioids and sensory nerves. Handb Exp Pharmacol 194:495-518.
31. Vaughan CW, Ingram SL, Connor MA, and Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:611-614.
32. Winter CA, Risley EA, and Nuss GW (1962) Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544-547.
33. World Health Organization (2013) WHO Model List of Essential Medicines, 18th ed, World Health Organization, Geneva, Switzerland.
34. Zhang WQ, Hua YL, Zhang M, Ji P, Li JX, Zhang L, Li PL, and Wei YM (2014) Metabonomic analysis of the anti-inflammatory effects of volatile oils of Angelica sinensis on rat model of acute inflammation. Biomed Chromatogr DOI: 10.1002/bmc.3372 [published ahead of print].
35. Zhang Z and Pan ZZ (2012) Signaling cascades for δ-opioid receptor-mediated inhibition of GABA synaptic transmission and behavioral antinociception. Mol Pharmacol 81:375-383.
36. Ziegler CM, Wiechnik J, and Mühling J (2010) Analgesic effects of intra-articular morphine in patients with temporomandibular joint disorders: a prospective, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg 68:622-627.